Ark Innovation ETF Delivers a Bumpy Ride
Some of the fund's growth stocks, including Tesla, suffered recently as investors turned toward value-priced shares.
Ark Innovation ETF (ARKK) had its proverbial day in the sun for most of the past year, but lately some clouds have appeared as the fund has given back some gains. Even so, its triple-digit return over the past 12 months beat all but 16 diversified U.S. stock and sector stock exchange-traded funds.
The actively managed ETF, run by Cathie Wood, focuses on fast-growing firms in innovative and disruptive industries.
Its current portfolio of 56 stocks comprises firms that are leading the way in genomics; innovation in energy, automation and manufacturing; next-gen internet infrastructure and services; and financial technology.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Some of the fund's best performers over the past year climbed more than 400%, including electric car maker Tesla (TSLA); Intellia Therapeutics (NTLA), which uses gene editing to create treatments; and Sea Ltd. (SE), an internet platform in Southeast Asia and Taiwan.
Recently, some of the fund's "growthier" stocks, including Tesla, have suffered as investors turned toward value-priced shares in more economically sensitive companies. All told, over the first 14 weeks of 2021, the fund slipped 1.0%, compared with a 10.4% gain in the S&P 500 Index.
Long-term investors with a healthy tolerance for risk would be wise to hang on. Management invests for long-term growth, says Todd Rosenbluth, CFRA's Head of ETF & Mutual Fund Research. "Investors should demonstrate patience, as there has been and will be volatility given the investment themes in focus," he says.
Indeed, a bumpy ride is part of the bargain with a high-growth fund like Ark Innovation, a member of the Kiplinger ETF 20.
Since the fund launched in October 2014, it has been nearly twice as volatile as the S&P 500 Index, but it has returned 34.5% annualized, compared with a 14.2% gain in the big-company benchmark.
Not all analysts are sanguine about the fund, however. Morningstar analyst Robby Greengold says the fund is vulnerable to key-person risk because Wood is the fund's lone manager.
High turnover in research analysts at the firm isn't good, either, he adds, because new analysts may lack experience. Those factors, among others, raise doubts about whether the fund's "outstanding historical results can continue," says Greengold.
Past performance is never a guarantee of future results, and a volatile fund such as this is bound to have draggy periods. But as long as the ETF has its proper place in your portfolio – as a sliver of high-growth exposure and not as a core holding – we would stick with it. Ark Invest says it did not have time for an interview.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Nellie joined Kiplinger in August 2011 after a seven-year stint in Hong Kong. There, she worked for the Wall Street Journal Asia, where as lifestyle editor, she launched and edited Scene Asia, an online guide to food, wine, entertainment and the arts in Asia. Prior to that, she was an editor at Weekend Journal, the Friday lifestyle section of the Wall Street Journal Asia. Kiplinger isn't Nellie's first foray into personal finance: She has also worked at SmartMoney (rising from fact-checker to senior writer), and she was a senior editor at Money.
-
This Late-in-Life Roth Conversion Opportunity Spares Your Heirs
Expensive medical care in the later stages of life is an unpleasant reality for many, but it can open a window for a Roth conversion that benefits your heirs.
By Evan T. Beach, CFP®, AWMA® Published
-
Women, What Is Your Net Worth?
Many women have no idea what their net worth is, or even how to calculate it. Many also turn to social media finfluencers for advice. Here's what to do instead.
By Neale Godfrey, Financial Literacy Expert Published
-
Stock Market Today: Stocks Jump Ahead of Trump Inauguration
The Dow and S&P 500 scored their biggest weekly gains since the early November election.
By Karee Venema Published
-
Stock Market Today: Stocks Pause After a Big Rally
The Nasdaq continues to lag the S&P 500 and the Dow so far in 2025.
By David Dittman Published
-
Stock Market Today: Dow Pops 703 Points on Cooler Inflation
A benign reading from the Consumer Price Index report assuaged market fears about the path of borrowing costs.
By Dan Burrows Published
-
Stock Market Today: Stocks Are Mixed Ahead of CPI
Cool wholesale inflation numbers provide only slight relief before Wednesday's release of December Consumer Price Index data.
By David Dittman Published
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Stock Market Today: Dow Slides 697 Points on Super-Hot Jobs Data
When the December nonfarm payrolls report hit the tape, there was no question which way stocks would go at Friday's opening bell.
By David Dittman Published
-
Blowout December Jobs Report Puts Rate Cuts on Ice: What the Experts Are Saying
Jobs Report The strongest surge in hiring since March keeps the Fed on hold for now.
By Dan Burrows Published
-
Stock Market Today: Stocks End Mixed After FOMC Minutes
The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
By Karee Venema Published